GVT
ZBH icon

Genesee Valley Trust’s Zimmer Biomet ZBH Stock Holding History

Genesee Valley Trust’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-2,267
Closed -$250K – 299
2014
Q4 		$250K Sell
2,267
-43
-2% -$4.53K 0.16% 193
2014
Q3 		$226K Sell
2,310
-446
-16% -$43.9K 0.14% 245
2014
Q2 		$278K Buy
+2,756
New +$269K 0.17% 222

Other funds holding ZBH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Genesee Valley Trust's ZBH Position: Q1 2015 in Review

Genesee Valley Trust sold out of Zimmer Biomet (ZBH) in Q1 2015, closing a stake of 2,267 shares — an estimated $250K sold.

Genesee Valley Trust first reported a position in ZBH in Q2 2014 and held it in 3 quarters. The position peaked at $278K in Q2 2014. 762 funds tracked by Wall St. Rank hold ZBH as of Q1 2015.

  • Genesee Valley Trust reported no remaining Zimmer Biomet position as of Q1 2015 after selling out during the quarter.
  • Genesee Valley Trust sold 2,267 Zimmer Biomet shares in Q1 2015, an estimated $250K.
  • Genesee Valley Trust first reported a position in Zimmer Biomet in Q2 2014 and held it in 3 quarters.
  • Genesee Valley Trust's Zimmer Biomet position peaked at $278K in Q2 2014.
  • 762 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2015.

Based on Genesee Valley Trust's 13F filing for Q1 2015, filed 7 May 2015.